relative to treatment alternatives to opioids.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 8 Sponsors 5

No summary has been published for this bill.

Chamber: House
Introduced: Jan 11, 2023
Last action: Nov 16, 2023 — Committee Report: Refer for Interim Study 11/06/2023 (Vote 20-0; CC)
Sponsor: David Lundgren R
Session: 2023
Momentum: 40 · Moderate

PASSAGE PROBABILITY

16.9% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -2 40/100 from the pace of recorded action
Time since last action -22 1059 days quiet
Cosponsors +6 4 signed on
Bipartisan support +9 1 D · 4 R
Sponsor influence -0 48/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.